Log in
Enquire now
‌

US Patent 10253344 Recombinant production of steviol glycosides

Patent 10253344 was granted and assigned to Conagen on April, 2019 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributors

Contents

Is a
Patent
Patent
0

Patent attributes

Patent Applicant
Conagen
Conagen
0
Current Assignee
Conagen
Conagen
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
102533440
Patent Inventor Names
Xiaodan Yu0
Guohong Mao0
Date of Patent
April 9, 2019
0
Patent Application Number
156310830
Date Filed
June 23, 2017
0
Patent Citations Received
‌
US Patent 11414689 Hydrolysis of steviol glycosides by beta-glucosidase
‌
US Patent 10724062 Biosynthetic production of steviol glycosides and processes therefore
‌
US Patent 11680281 Biosynthetic production of steviol glycosides and processes therefore
0
Patent Primary Examiner
‌
Robert B Mondesi
0
Patent abstract

Recombinant polypeptides having UDP-glycosyltransferase activities, including a 1,2-19-O-glucose glycosylation activity and a 1,2-13-O-glucose glycosylation activity for synthesizing of steviol glucosides, are provided. A method of producing a steviol glycoside composition using such recombinant polypeptide is also provided. Also disclosed are steviol glycosides referred to as rebaudioside Z1 and rebaudioside Z2.

Timeline

No Timeline data yet.

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more entities like US Patent 10253344 Recombinant production of steviol glycosides

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.